Local Institution

Wollongong, New South Wales 2500

0 studies enrolling now · 7 studies all time

What they study most

Cancer, Hepatocellular, Diabetes Mellitus, Diabetes Mellitus II, Diabetes, Type 2, Lung Cancer, Metabolics Diabetes Nos, Small Cell Lung Carcinoma

Studies at this site

• A Study of Nivolumab and Ipilimumab and Nivolumab Alone in Combination With Trans-arterial ChemoEmbolization (TACE) in Participants With Intermediate Stage Liver Cancer — Completed
• An Investigational Immuno-therapy Study of Nivolumab, or Nivolumab in Combination With Ipilimumab, or Placebo in Patients With Extensive-Stage Disease Small Cell Lung Cancer (ED-SCLC) After Completion of Platinum-based Chemotherapy — Completed
• Trial in Extensive-Disease Small Cell Lung Cancer (ED-SCLC) Subjects Comparing Ipilimumab Plus Etoposide and Platinum Therapy to Etoposide and Platinum Therapy Alone — Completed
• A Trial to Evaluate BMS-298585 as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control — Completed
• PPAR - Combination With Metformin — Completed
• PPAR-COMBO With Sulfonylurea — Completed
• Dose Ranging Study With LT, Monotherapy, PPAR — Completed